Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices
Open Access
- 20 May 2004
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 76 (2) , 388-398
- https://doi.org/10.1189/jlb.0503221
Abstract
Proteinase‐activated receptor‐2 (PAR2) belongs to a novel subfamily of G‐protein‐coupled receptors with seven‐transmembrane domains. PAR2 can be activated by serine proteases such as trypsin, mast cell tryptase, and allergic or bacterial proteases. This receptor is expressed by various cells and seems to be crucially involved during inflammation and the immune response. As previously reported, human neutrophils express functional PAR2. However, the precise physiological role of PAR2 on human neutrophils and its implication in human diseases remain unclear. We demonstrate that PAR2 agonist‐stimulated human neutrophils show significantly enhanced migration in 3‐D collagen lattices. PAR2 agonist stimulation also induced down‐regulation of L‐selectin display and up‐regulation of membrane‐activated complex‐1 very late antigen‐4 integrin expression on the neutrophil cell surface. Moreover, PAR2 stimulation results in an increased secretion of the cytokines interleukin (IL)‐1β, IL‐8, and IL‐6 by human neutrophils. These data indicate that PAR2 plays an important role in human neutrophil activation and may affect key neutrophil functions by regulating cell motility in the extracellular matrix, selectin shedding, and up‐regulation of integrin expression and by stimulating the secretion of inflammatory mediators. Thus, PAR2 may represent a potential therapeutic target for the treatment of diseases involving activated neutrophils.Keywords
Funding Information
- Federal Ministry of Education and Research (IZKF, Fö.01KS9604/0, DFG STE 1014, SFB 293)
- Boltzmann-Institute, Münster, Germany
- Rosacea Foundation, USA
- Schering Foundation
- Boehringer-Ingelheim Fonds
- Canadian Institutes for Health Research
- The Kidney Foundation of Canada
- The Heart and Stroke Foundation of Canada
- Ileitis Colitis Foundation
This publication has 52 references indexed in Scilit:
- Proinflammatory role of proteinase‐activated receptor‐2 in humans and mice during cutaneous inflammation in vivoThe FASEB Journal, 2003
- Fibrinogen‐CD11b/CD18 interaction activates the NF‐κB pathway and delays apoptosis in human neutrophilsEuropean Journal of Immunology, 2003
- International Union of Pharmacology. XXVIII. Proteinase-Activated ReceptorsPharmacological Reviews, 2002
- Discoidin domain receptor 1 isoform‐a (DDRla) promotes migration of leukocytes in three‐dimensional collagen latticesThe FASEB Journal, 2001
- Decoupling of Intracellular Calcium Signaling in Granulocytes After Exhaustive ExerciseInternational Journal of Sports Medicine, 2001
- Proteinase-activated receptors (PARs): activation of PAR1 and PAR2 by a proteolytic fragment of the neuronal growth associated protein B-50/GAP-43Canadian Journal of Physiology and Pharmacology, 2000
- IL-1β STIMULATION INDUCES PARACRINE REGULATION OF PMN FUNCTION AND APOPTOSISShock, 1999
- Endothelium‐dependent contractile actions of proteinase‐activated receptor‐2‐activating peptides in human umbilical vein: release of a contracting factor via a novel receptorBritish Journal of Pharmacology, 1998
- Interleukin-6 Delays Neutrophil Apoptosis via a Mechanism Involving Platelet-Activating FactorThe Journal of Trauma: Injury, Infection, and Critical Care, 1996
- Molecular Cloning and Functional Expression of the Gene Encoding the Human Proteinase‐Activated Receptor 2European Journal of Biochemistry, 1995